Exercise transiently increases the density of incipient blood clots in antiplatelet-treated lacunar stroke patients
Nørregaard, L B, Wickham, K A, Jeppesen, J S, Rytter, N, Christoffersen, L C, Gliemann, L, Lawrence, M, Evans, P A, Kruuse, C, Hellsten, Y
Published in Thrombosis journal (05.04.2024)
Published in Thrombosis journal (05.04.2024)
Get full text
Journal Article
CI-1007, a dopamine partial agonist and potential antipsychotic agent. II. Neurophysiological and behavioral effects
Meltzer, L T, Christoffersen, C L, Corbin, A E, Ninteman, F W, Serpa, K A, Wiley, J N, Wise, L D, Heffner, T G
Published in The Journal of pharmacology and experimental therapeutics (01.08.1995)
Get full text
Published in The Journal of pharmacology and experimental therapeutics (01.08.1995)
Journal Article
Pharmacological profile of the dopamine partial agonist, (+/-)-PD 128483 and its enantiomers
MELTZER, L. T, CAPRATHE, B. W, WILEY, J. N, WISE, L. D, HEFFNER, T. G, CHRISTOFFERSEN, C. L, CORBIN, A. E, JAEN, J. C, NINTEMAN, F. W, PUGSLEY, T. A, SERPA, K. A, SHIH, Y.-H, WHETZEL, S. Z
Published in The Journal of pharmacology and experimental therapeutics (01.09.1993)
Get full text
Published in The Journal of pharmacology and experimental therapeutics (01.09.1993)
Journal Article
Pharmacokinetics and pharmacodynamics of an investigational antipsychotic agent, CI-1007, in rats and monkeys
FENG, M. R, CORBIN, A. E, WRIGHT, D. S, WANG, Y, CHRISTOFFERSEN, C. L, WILEY, J. N, STRENKOSKI, C. A, TUCKER, E. V, NINTEMAN, F. W, MELTZER, L. T, HEFFNER, T. G
Published in Pharmaceutical research (01.03.1997)
Published in Pharmaceutical research (01.03.1997)
Get full text
Journal Article
Lack of involvement of haloperidol-sensitive sigma binding sites in modulation of dopamine neuronal activity and induction of dystonias by antipsychotic drugs
Meltzer, L T, Christoffersen, C L, Serpa, K A, Pugsley, T A, Razmpour, A, Heffner, T G
Published in Neuropharmacology (01.09.1992)
Published in Neuropharmacology (01.09.1992)
Get more information
Journal Article
PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT(1A) agonist actions. II. Preclinical behavioral effects
Corbin, A E, Meltzer, L T, Ninteman, F W, Wiley, J N, Christoffersen, C L, Wustrow, D J, Wise, L D, Pugsley, T A, Heffner, T G
Published in Neuropharmacology (27.04.2000)
Published in Neuropharmacology (27.04.2000)
Get full text
Journal Article
Comparison of the effects of the cholecystokinin-B receptor antagonist, PD 134308, and the cholecystokinin-A receptor antagonist, L-364,718, on dopamine neuronal activity in the substantia nigra and ventral tegmental area
Meltzer, L T, Christoffersen, C L, Serpa, K A, Razmpour, A
Published in Synapse (New York, N.Y.) (01.02.1993)
Published in Synapse (New York, N.Y.) (01.02.1993)
Get more information
Journal Article
PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT1A agonist actions. II. Preclinical behavioral effects
CORBIN, A. E, MELTZER, L. T, NINTEMAN, F. W, WILEY, J. N, CHRISTOFFERSEN, C. L, WUSTROW, D. J, WISE, L. D, PUGSLEY, T. A, HEFFNER, T. G
Published in Neuropharmacology (01.06.2000)
Published in Neuropharmacology (01.06.2000)
Get full text
Journal Article
PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT sub(1A) agonist actions. II. Preclinical behavioral effects
Corbin, A E, Meltzer, L T, Ninteman, F W, Wiley, J N, Christoffersen, CL, Wustrow, D J, Wise, L D, Pugsley, T A, Heffner, T G
Published in Neuropharmacology (01.04.2000)
Get full text
Published in Neuropharmacology (01.04.2000)
Journal Article
Cl-1007, a dopamine partial agonist and potential antipsychotic agent. II. Neurophysiological and behavioral effects
Meltzer, L T, Christoffersen, CL, Corbin, A E, Ninteman, F W, Serpa, KA, Wiley, J N, Wise, L D, Heffner, T G
Published in The Journal of pharmacology and experimental therapeutics (01.01.1995)
Get full text
Published in The Journal of pharmacology and experimental therapeutics (01.01.1995)
Journal Article